Re: Nader Al Nakouzi, Sylvestre Le Moulec, Laurence Albiges, et al. Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2014.04.015

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)E71-E72
JournalEuropean Urology
Volume66
Issue number4
DOIs
Publication statusPublished - 2014

Cite this